Javascript must be enabled to continue!
Fosfomycin, trimethoprim/sulfamethoxazole, or ciprofloxacin: which is better for infection prophylaxis with transrectal prostatic biopsy? Multicenter study
View through CrossRef
Abstract
Background
Antibiotic prophylaxis is necessary to avoid infectious complications following transrectal ultrasound-guided prostate biopsy (TRUSPB). Till now, there is no consensus or international agreement for the optimal type of antibiotics, particularly after the recommendation against using fluoroquinolones as antibiotic prophylaxis due to their toxicity profile and the increasing bacterial resistance to them.
Aim of the work
This study aimed to retrospectively compare the efficacy of ciprofloxacin, trimethoprim/sulfamethoxazole, or fosfomycin as perioperative prophylaxis in patients undergoing TRUSBP.
Patients and methods
We retrospectively analyzed 502 patients who underwent TRUSPB in 2 urological facilities in Egypt and Germany between June 2020 and July 2023 and received either ciprofloxacin (n: 121), trimethoprim/sulfamethoxazole (n: 109), or fosfomycin (n: 272) as antibiotic prophylaxis. Infection rate and site and sepsis rates were assessed within 1 month after the procedure. The causative organism, management protocol, and antibiotics used in management were also studied.
Results
Infections developed among 3.3% of patients who received fosfomycin, 2.8% who received trimethoprim/sulfamethoxazole, and 0.8% who received ciprofloxacin. The results showed no statistically significant difference among the 3 arms. In Egypt and Germany E. coli was the most common causative Organism. Although there were different management strategies between Egypt and Germany, there was no fatal complication or intensive care admission in the three groups.
Conclusions
Fosfomycin, ciprofloxacin, and trimethoprim/sulfamethoxazole effectively prevent post-transrectal prostate biopsy infections. Further research is needed to evaluate the efficacy and safety of different types of antibiotics in different populations in which regional variations in pathogen prevalence and resistance patterns should be considered.
Springer Science and Business Media LLC
Title: Fosfomycin, trimethoprim/sulfamethoxazole, or ciprofloxacin: which is better for infection prophylaxis with transrectal prostatic biopsy? Multicenter study
Description:
Abstract
Background
Antibiotic prophylaxis is necessary to avoid infectious complications following transrectal ultrasound-guided prostate biopsy (TRUSPB).
Till now, there is no consensus or international agreement for the optimal type of antibiotics, particularly after the recommendation against using fluoroquinolones as antibiotic prophylaxis due to their toxicity profile and the increasing bacterial resistance to them.
Aim of the work
This study aimed to retrospectively compare the efficacy of ciprofloxacin, trimethoprim/sulfamethoxazole, or fosfomycin as perioperative prophylaxis in patients undergoing TRUSBP.
Patients and methods
We retrospectively analyzed 502 patients who underwent TRUSPB in 2 urological facilities in Egypt and Germany between June 2020 and July 2023 and received either ciprofloxacin (n: 121), trimethoprim/sulfamethoxazole (n: 109), or fosfomycin (n: 272) as antibiotic prophylaxis.
Infection rate and site and sepsis rates were assessed within 1 month after the procedure.
The causative organism, management protocol, and antibiotics used in management were also studied.
Results
Infections developed among 3.
3% of patients who received fosfomycin, 2.
8% who received trimethoprim/sulfamethoxazole, and 0.
8% who received ciprofloxacin.
The results showed no statistically significant difference among the 3 arms.
In Egypt and Germany E.
coli was the most common causative Organism.
Although there were different management strategies between Egypt and Germany, there was no fatal complication or intensive care admission in the three groups.
Conclusions
Fosfomycin, ciprofloxacin, and trimethoprim/sulfamethoxazole effectively prevent post-transrectal prostate biopsy infections.
Further research is needed to evaluate the efficacy and safety of different types of antibiotics in different populations in which regional variations in pathogen prevalence and resistance patterns should be considered.
Related Results
Challenging Management of Postoperative Empyema: A Case Report with Literature Review
Challenging Management of Postoperative Empyema: A Case Report with Literature Review
Abstract
Introduction: Pleural empyema is the collection of pus within the pleural cavity, typically arising as a complication of pneumonia, chest trauma, thoracic surgery, or bact...
611. Fosfomycin Resistance of Multidrug-Resistant Escherichia coli and Mechanisms of Fosfomycin Resistance
611. Fosfomycin Resistance of Multidrug-Resistant Escherichia coli and Mechanisms of Fosfomycin Resistance
Abstract
Background
Fosfomycin is one of the antibiotics that may be a candidate for the next-generation antimicrobial agents ag...
Fosfomycin versus ciprofloxacin for transrectal prostate biopsy: An open randomised controlled multicentre drug trial
Fosfomycin versus ciprofloxacin for transrectal prostate biopsy: An open randomised controlled multicentre drug trial
Objective:
Antibiotic prophylaxis reduces infection risk following transrectal prostate biopsy. Studies in countries with high antibiotic resistance show that f...
COMPARISON OF FOSFOMYCIN TROMETAMOL WITH CIPROFLOXACIN FOR UNCOMPLICATED UTI DUE TO E.COLI IN WOMEN
COMPARISON OF FOSFOMYCIN TROMETAMOL WITH CIPROFLOXACIN FOR UNCOMPLICATED UTI DUE TO E.COLI IN WOMEN
Objective: To compare clinical therapeutic effects (frequency, dysuria, and pyuria), microbiology, pharmacokinetics index Cmax/MIC Fosfomycin Trometamol 3 gr single dose with Cipro...
A genome wide analysis ofEscherichia coliresponses to fosfomycin using TraDIS-Xpress reveals novel roles for phosphonate and phosphate transport systems
A genome wide analysis ofEscherichia coliresponses to fosfomycin using TraDIS-Xpress reveals novel roles for phosphonate and phosphate transport systems
AbstractFosfomycin is an antibiotic which has seen a revival in use due to its unique mechanism of action and resulting efficacy against isolates resistant to many other antibiotic...
Antibacterial Activity of Paracetamol, Trimethoprim/sulfamethoxazole, Azithromycin, and Ciprofloxacin
Antibacterial Activity of Paracetamol, Trimethoprim/sulfamethoxazole, Azithromycin, and Ciprofloxacin
Paracetamol have indirect antibiotic activity and are commonly coadministered with antimicrobial therapy. This study aimed to assess the synergistic effect of Paracetamol to with A...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Antimicrobial activity of ciprofloxacin-coated gold nanoparticles on selected pathogens
Antimicrobial activity of ciprofloxacin-coated gold nanoparticles on selected pathogens
Antibiotic resistance amongst bacterial pathogens is a crisis that has been worsening over recent decades, resulting in serious and often fatal infections that cannot be treated by...

